| LPERX | RLLGX | LPERX / RLLGX | |
| Total Expense Ratio | 2.12 | 0.65 | 326% |
| Annual Report Gross Expense Ratio | 2.15 | 0.65 | 331% |
| Fund Existence | 19 years | 17 years | - |
| Gain YTD | -0.557 | 14.864 | -4% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 0 | 250 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 45.1M | 89B | 0% |
| Annual Yield % from dividends | 8.19 | 0.90 | 909% |
| Returns for 1 year | -15.26 | 15.82 | -97% |
| Returns for 3 years | 11.72 | 42.42 | 28% |
| Returns for 5 years | -18.58 | -0.62 | 2,983% |
| Returns for 10 years | 35.94 | 90.37 | 40% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| MGKCX | 11.53 | 0.22 | +1.95% |
| Morgan Stanley Global Permanence C | |||
| JHUJX | 51.26 | 0.52 | +1.02% |
| JPMorgan Emerging Markets Equity R2 | |||
| BIVIX | 19.04 | 0.13 | +0.69% |
| Invenomic Institutional | |||
| ESPRX | 42.38 | 0.23 | +0.55% |
| Allspring Special Small Cap Value R6 | |||
| NAEFX | 86.35 | -0.17 | -0.20% |
| New Alternatives Investor | |||